Novartis andUPenn to work on cellular therapies

Monday 6 August 2012

Novartis has announced plans to invest in a new Center for Advanced Cellular Therapies at the University of Pennsylvania in the US to research immunotherapies for patients with cancer using chimeric antigen receptor (CAR) technologies.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland